ロード中...
Diclofenac and the Risk of Rhabdomyolysis: Analysis of Publications and the WHO Global Pharmacovigilance Database
BACKGROUND: Diclofenac, a nonsteroidal anti-inflammatory drug, is not a documented cause of rhabdomyolysis in the Summaries of Product Characteristics held by major regulators. There are, however, eight published single case reports that associate rhabdomyolysis with diclofenac. OBJECTIVE: Triggered...
保存先:
| 出版年: | Drugs Real World Outcomes |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer International Publishing
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8324666/ https://ncbi.nlm.nih.gov/pubmed/33786776 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40801-021-00240-z |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|